Clinical Trials List
2009-06-01 - 2012-12-31
Phase II
Terminated1
Study ended4
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- KO-JEN LI Division of Rheumatology
- SONG-CHOU HSIEH Division of Rheumatology
- PING-NING HSU Division of Rheumatology
- CHENG-HAN WU Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Po-Hao Huang 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Chang-Fu Kuo Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
429 participants
